Sickle Cell Anemia Therapeutics Market - Global Outlook and Forecast 2021-2027

Sickle Cell Anemia Therapeutics Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ777055 | No. of Pages: 105 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jun-2021
This report contains market size and forecasts of Sickle Cell Anemia Therapeutics in Global, including the following market information:
Global Sickle Cell Anemia Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Sickle Cell Anemia Therapeutics market was valued at 3108.9 million in 2020 and is projected to reach US$ 4639.6 million by 2027, at a CAGR of 10.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sickle Cell Anemia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sickle Cell Anemia Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Sickle Cell Anemia Therapeutics Market Segment Percentages, By Type, 2020 (%)
    Blood Transfusion
    Pharmacotherapy
    Bone Marrow Transplant

China Sickle Cell Anemia Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Sickle Cell Anemia Therapeutics Market Segment Percentages, By Application, 2020 (%)
    Hospitals
    Clinics
    Others

Global Sickle Cell Anemia Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Sickle Cell Anemia Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Sickle Cell Anemia Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Sickle Cell Anemia Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
    BioMarin
    Bluebird Bio
    DeuteRx
    Emmaus Medical
    Gamida Cell
    Global Blood Therapeutics
    GlycoMimetics
    Modus Therapeutics
    Pfizer
    Sancilio Pharmaceuticals
    Sangamo Biosciences
1 Introduction to Research & Analysis Reports
    1.1 Sickle Cell Anemia Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Sickle Cell Anemia Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Sickle Cell Anemia Therapeutics Overall Market Size
    2.1 Global Sickle Cell Anemia Therapeutics Market Size: 2021 VS 2027
    2.2 Global Sickle Cell Anemia Therapeutics Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Sickle Cell Anemia Therapeutics Players in Global Market
    3.2 Top Global Sickle Cell Anemia Therapeutics Companies Ranked by Revenue
    3.3 Global Sickle Cell Anemia Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Sickle Cell Anemia Therapeutics Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Sickle Cell Anemia Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Sickle Cell Anemia Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Sickle Cell Anemia Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Sickle Cell Anemia Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Sickle Cell Anemia Therapeutics Market Size Markets, 2021 & 2027
        4.1.2 Blood Transfusion
        4.1.3 Pharmacotherapy
        4.1.4 Bone Marrow Transplant
    4.2 By Type - Global Sickle Cell Anemia Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Sickle Cell Anemia Therapeutics Revenue, 2016-2021
        4.2.2 By Type - Global Sickle Cell Anemia Therapeutics Revenue, 2022-2027
        4.2.3 By Type - Global Sickle Cell Anemia Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Sickle Cell Anemia Therapeutics Market Size, 2021 & 2027
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Sickle Cell Anemia Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Sickle Cell Anemia Therapeutics Revenue, 2016-2021
        5.2.2 By Application - Global Sickle Cell Anemia Therapeutics Revenue, 2022-2027
        5.2.3 By Application - Global Sickle Cell Anemia Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Sickle Cell Anemia Therapeutics Market Size, 2021 & 2027
    6.2 By Region - Global Sickle Cell Anemia Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Sickle Cell Anemia Therapeutics Revenue, 2016-2021
        6.2.2 By Region - Global Sickle Cell Anemia Therapeutics Revenue, 2022-2027
        6.2.3 By Region - Global Sickle Cell Anemia Therapeutics Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Sickle Cell Anemia Therapeutics Revenue, 2016-2027
        6.3.2 US Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.3.3 Canada Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.3.4 Mexico Sickle Cell Anemia Therapeutics Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Sickle Cell Anemia Therapeutics Revenue, 2016-2027
        6.4.2 Germany Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.4.3 France Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.4.4 U.K. Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.4.5 Italy Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.4.6 Russia Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.4.7 Nordic Countries Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.4.8 Benelux Sickle Cell Anemia Therapeutics Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Sickle Cell Anemia Therapeutics Revenue, 2016-2027
        6.5.2 China Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.5.3 Japan Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.5.4 South Korea Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.5.5 Southeast Asia Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.5.6 India Sickle Cell Anemia Therapeutics Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Sickle Cell Anemia Therapeutics Revenue, 2016-2027
        6.6.2 Brazil Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.6.3 Argentina Sickle Cell Anemia Therapeutics Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Sickle Cell Anemia Therapeutics Revenue, 2016-2027
        6.7.2 Turkey Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.7.3 Israel Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.7.4 Saudi Arabia Sickle Cell Anemia Therapeutics Market Size, 2016-2027
        6.7.5 UAE Sickle Cell Anemia Therapeutics Market Size, 2016-2027
7 Players Profiles
    7.1 BioMarin
        7.1.1 BioMarin Corporate Summary
        7.1.2 BioMarin Business Overview
        7.1.3 BioMarin Sickle Cell Anemia Therapeutics Major Product Offerings
        7.1.4 BioMarin Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.1.5 BioMarin Key News
    7.2 Bluebird Bio
        7.2.1 Bluebird Bio Corporate Summary
        7.2.2 Bluebird Bio Business Overview
        7.2.3 Bluebird Bio Sickle Cell Anemia Therapeutics Major Product Offerings
        7.2.4 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.2.5 Bluebird Bio Key News
    7.3 DeuteRx
        7.3.1 DeuteRx Corporate Summary
        7.3.2 DeuteRx Business Overview
        7.3.3 DeuteRx Sickle Cell Anemia Therapeutics Major Product Offerings
        7.3.4 DeuteRx Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.3.5 DeuteRx Key News
    7.4 Emmaus Medical
        7.4.1 Emmaus Medical Corporate Summary
        7.4.2 Emmaus Medical Business Overview
        7.4.3 Emmaus Medical Sickle Cell Anemia Therapeutics Major Product Offerings
        7.4.4 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.4.5 Emmaus Medical Key News
    7.5 Gamida Cell
        7.5.1 Gamida Cell Corporate Summary
        7.5.2 Gamida Cell Business Overview
        7.5.3 Gamida Cell Sickle Cell Anemia Therapeutics Major Product Offerings
        7.5.4 Gamida Cell Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.5.5 Gamida Cell Key News
    7.6 Global Blood Therapeutics
        7.6.1 Global Blood Therapeutics Corporate Summary
        7.6.2 Global Blood Therapeutics Business Overview
        7.6.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Major Product Offerings
        7.6.4 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.6.5 Global Blood Therapeutics Key News
    7.7 GlycoMimetics
        7.7.1 GlycoMimetics Corporate Summary
        7.7.2 GlycoMimetics Business Overview
        7.7.3 GlycoMimetics Sickle Cell Anemia Therapeutics Major Product Offerings
        7.4.4 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.7.5 GlycoMimetics Key News
    7.8 Modus Therapeutics
        7.8.1 Modus Therapeutics Corporate Summary
        7.8.2 Modus Therapeutics Business Overview
        7.8.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Major Product Offerings
        7.8.4 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.8.5 Modus Therapeutics Key News
    7.9 Pfizer
        7.9.1 Pfizer Corporate Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Sickle Cell Anemia Therapeutics Major Product Offerings
        7.9.4 Pfizer Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.9.5 Pfizer Key News
    7.10 Sancilio Pharmaceuticals
        7.10.1 Sancilio Pharmaceuticals Corporate Summary
        7.10.2 Sancilio Pharmaceuticals Business Overview
        7.10.3 Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Major Product Offerings
        7.10.4 Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.10.5 Sancilio Pharmaceuticals Key News
    7.11 Sangamo Biosciences
        7.11.1 Sangamo Biosciences Corporate Summary
        7.11.2 Sangamo Biosciences Business Overview
        7.11.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Major Product Offerings
        7.11.4 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue in Global (2016-2021)
        7.11.5 Sangamo Biosciences Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com